Arthroscopic Suprapectoral and Open Subpectoral Biceps Tenodeses Produce Similar Outcomes: A Randomized Prospective Analysis.


Journal

Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association
ISSN: 1526-3231
Titre abrégé: Arthroscopy
Pays: United States
ID NLM: 8506498

Informations de publication

Date de publication:
01 2020
Historique:
received: 09 04 2019
revised: 01 07 2019
accepted: 03 07 2019
entrez: 23 12 2019
pubmed: 23 12 2019
medline: 21 10 2020
Statut: ppublish

Résumé

To directly compare subjective and objective outcomes of arthroscopic suprapectoral biceps tenodesis (ASPBT) below the bicipital groove and open subpectoral biceps tenodesis (OSPBT) performed with interference screw fixation. A total of 77 patients indicated for biceps tenodesis who met the inclusion and exclusion criteria were randomized into the ASPBT and OSPBT groups. All tenodesis procedures implemented PEEK (polyether ether ketone) interference screws. Patients underwent a clinical examination that included range of motion and strength assessment at 3, 6, and 12 months postoperatively. Patients completed the American Shoulder and Elbow Surgeons (ASES) shoulder score, Single Assessment Numeric Evaluation score, and Constant score preoperatively and at 6 and 12 months postoperatively. Seventy-five patients were analyzed with a mean age of 50.3 ± 10.4 years and a mean body mass index of 28.9 ± 6.3. All patients had arthroscopic evidence of biceps pathology and underwent either an ASPBT (n = 37) or OSPBT (n = 38). The surgical time was significantly greater for ASPBT than for OSPBT (16.9 ± 8.4 minutes vs 9.8 ± 3.1 minutes, P < .001). One patient underwent conversion from the ASPBT group to the OSPBT group because of shearing of a severely attenuated tendon preventing an ASPBT. No significant difference (P > .05) was found in strength or anterior shoulder pain at 3 months, 6 months, and 1 year, and no significant difference (P > .05) was found in clinical outcome scores (ASES, Constant subjective, and Single Assessment Numeric Evaluation) between the 2 groups at 6 months and 1 year. The improvement in the ASES score exceeded the minimal clinically important difference (12 points) in both groups. No differences in patient-reported outcome measures, functional outcomes, or complication rates were found after ASPBT compared with OSPBT. However, the results of this investigation must be interpreted with caution because this study may be underpowered to detect statistical differences. Level I, randomized controlled trial.

Identifiants

pubmed: 31864581
pii: S0749-8063(19)30629-2
doi: 10.1016/j.arthro.2019.07.009
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

23-32

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.

Auteurs

Brian Forsythe (B)

Midwest Orthopaedics at Rush, Rush University Medical Center, Chicago, Illinois, U.S.A.. Electronic address: brian.forsythe@rushortho.com.

William A Zuke (WA)

Department of Orthopaedic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A.

Avinesh Agarwalla (A)

Department of Orthopaedic Surgery, Westchester Medical Center, Valhalla, New York, U.S.A.

Richard N Puzzitiello (RN)

Department of Orthopaedic Surgery, Tufts University Medical Center, Boston, Massachusetts, U.S.A.

Grant H Garcia (GH)

Seattle Orthopaedic Center, Seattle, Washington, U.S.A.

Gregory L Cvetanovich (GL)

Division of Sports Medicine, Department of Orthopaedics, The Ohio State University Wexner Medical Center, Columbus, Ohio.

Adam B Yanke (AB)

Midwest Orthopaedics at Rush, Rush University Medical Center, Chicago, Illinois, U.S.A.

Nikhil N Verma (NN)

Midwest Orthopaedics at Rush, Rush University Medical Center, Chicago, Illinois, U.S.A.

Anthony A Romeo (AA)

Department of Orthopaedic Surgery, Rothman Institute, Philadelphia, Pennsylvania, U.S.A.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH